- Conditions: Depressive Disorder; Anxiety Disorder
Interventions: Drug: Lu AA21004; Drug: Lu AA21004; Drug: Lu AA21004; Drug: Lu AA21004
Sponsors: H. Lundbeck A/S; H. Lundbeck A/S
Recruiting - verified April 2012 - Conditions: Cigarette Smoking; Drug Use
Interventions: Behavioral: Standard Treatment; Behavioral: BAD-AS; Drug: Transdermal Nicotine Patch
Sponsors: University of Maryland; University of Maryland; American Cancer Society
Recruiting - verified July 2011 - Condition: Treatment Outcome
Interventions: Drug: Lu AA21004; Drug: Escitalopram
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Center, Inc.
Recruiting - verified May 2012 - Condition: Major Depressive Disorder
Intervention: Drug: Escitalopram
Sponsors: Forest Laboratories; Forest Laboratories
Recruiting - verified February 2012 - Condition: Depression
Intervention: Drug: Armodafinil
Sponsors: Teva Pharmaceutical Industries; Cephalon
Recruiting - verified May 2012 - Condition: Depression
Interventions: Drug: Armodafinil; Drug: Armodafinil; Drug: Placebo
Sponsors: Teva Pharmaceutical Industries; Cephalon
Recruiting - verified May 2012 - Conditions: Bipolar Disorder; Depression; Anxiety Disorders; Schizophrenia; Tourette's Syndrome; Brain Diseases
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified February 2012


